The OECD’s Annual Meeting at Ministerial Level reinforced member governments’ support across a broad range of key OECD work.
Governments would benefit from agreeing common principles for developing and communicating scientific advice, both in crisis situations and for long-term policymaking, according to a new OECD report.
The current policy approach to tackling dementia is socially and economically unsustainable, according to a new OECD report. Countries need to take action now to improve the lives of people living with dementia and their carers, prioritise public research on dementia, and improve the incentives for private investment in dementia innovation.
Squeezed R&D budgets in the EU, Japan and US are reducing the weight of advanced economies in science and technology research, patent applications and scientific publications and leaving China on track to be the world’s top R&D spender by around 2019, according to a new OECD report.
Encouraging private-sector innovation, making public research institutions more accountable and channelling more funds into the most promising R&D projects would help restore France’s former prowess in science and technology, a new OECD report says.
Young firms play a crucial role in job creation but have missed out on many of the benefits of structural reforms of the past decade in OECD countries.
Most OECD governments use tax incentives to encourage businesses to invest in research and development (R&D) to boost innovation and drive economic growth. Others, like China, India and South Africa, are doing the same. But reforming these incentives would give countries a better return on their investment and support young innovative firms that play a crucial role in job creation, according to a new OECD report.
The OECD has recommended its Member Countries apply existing international and national chemical regulatory frameworks to manage the risks associated with manufactured nanomaterials.
OECD countries must ensure mobile markets remain open and competitive in order to sustain innovation and meet rising demand for data services, according to a new OECD report.
Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leading to a decline in the number of international trials conducted by academics for non-commerical purposes.